Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
China · Delayed Price · Currency is CNY 4.380
0.00 (0.00%)
Jun 9, 2026, 3:04 PM CST
SHE:000597 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 6,251 | 7,449 | 7,531 | 7,646 | 9,051 | 8,384 | |
Market Cap Growth | -15.89% | -1.09% | -1.49% | -15.52% | 7.95% | 22.43% |
Enterprise Value | 4,254 | 5,445 | 4,778 | 5,667 | 7,484 | 8,815 |
Last Close Price | 4.38 | 5.22 | 5.17 | 5.13 | 5.95 | 5.85 |
PE Ratio | 25.05 | 28.64 | 18.38 | 21.33 | 25.84 | 84.66 |
Forward PE | - | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 |
PS Ratio | 0.88 | 1.05 | 1.00 | 0.93 | 1.03 | 1.03 |
PB Ratio | 1.10 | 1.31 | 1.35 | 1.48 | 1.92 | 1.95 |
P/TBV Ratio | 1.31 | 1.58 | 1.68 | 1.79 | 2.37 | 2.42 |
P/FCF Ratio | 5.87 | 7.39 | 12.57 | 21.76 | 10.47 | 13.38 |
P/OCF Ratio | 5.42 | 6.73 | 9.93 | 13.03 | 8.16 | 11.23 |
EV/Sales Ratio | 0.60 | 0.77 | 0.64 | 0.69 | 0.85 | 1.08 |
EV/EBITDA Ratio | 5.67 | 7.09 | 4.66 | 6.22 | 9.92 | 12.20 |
EV/EBIT Ratio | 18.87 | 21.09 | 10.04 | 15.48 | 34.09 | 41.85 |
EV/FCF Ratio | 3.99 | 5.40 | 7.97 | 16.13 | 8.66 | 14.07 |
Debt / Equity Ratio | 0.32 | 0.37 | 0.29 | 0.42 | 0.47 | 0.58 |
Debt / EBITDA Ratio | 2.46 | 2.66 | 1.52 | 2.32 | 2.81 | 3.27 |
Debt / FCF Ratio | 1.73 | 2.09 | 2.66 | 6.21 | 2.54 | 3.97 |
Net Debt / Equity Ratio | -0.37 | -0.26 | -0.52 | -0.67 | -0.35 | -0.01 |
Net Debt / EBITDA Ratio | -2.93 | -1.94 | -2.80 | -3.80 | -2.18 | -0.09 |
Net Debt / FCF Ratio | -2.00 | -1.48 | -4.80 | -9.87 | -1.91 | -0.10 |
Asset Turnover | 0.53 | 0.52 | 0.51 | 0.57 | 0.65 | 0.64 |
Inventory Turnover | 3.77 | 3.71 | 3.53 | 3.97 | 4.50 | 4.04 |
Quick Ratio | 0.96 | 0.95 | 0.87 | 0.86 | 0.78 | 0.65 |
Current Ratio | 1.15 | 1.15 | 1.05 | 1.02 | 0.94 | 0.83 |
Return on Equity (ROE) | 3.52% | 3.88% | 7.89% | 7.62% | 7.93% | 2.27% |
Return on Assets (ROA) | 1.04% | 1.18% | 2.00% | 1.57% | 1.02% | 1.04% |
Return on Invested Capital (ROIC) | 4.33% | 5.36% | 15.47% | 11.86% | 4.09% | 3.53% |
Return on Capital Employed (ROCE) | 3.60% | 4.10% | 7.70% | 6.40% | 4.10% | 4.20% |
Earnings Yield | 4.01% | 3.49% | 5.44% | 4.69% | 3.87% | 1.18% |
FCF Yield | 17.04% | 13.54% | 7.96% | 4.59% | 9.55% | 7.47% |
Dividend Yield | 1.26% | 1.05% | 1.93% | 1.95% | 1.68% | 0.24% |
Payout Ratio | 70.79% | 75.71% | 50.30% | 61.31% | 31.25% | 167.14% |
Buyback Yield / Dilution | -1.11% | -2.23% | 1.43% | -2.34% | 0.97% | -15.42% |
Total Shareholder Return | 0.13% | -1.18% | 3.37% | -0.40% | 2.65% | -15.18% |